Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Computer vision programs in medicine: dataset development, classification, and clinical use

https://doi.org/10.17749/2070-4909/farmakoekonomika.2026.374

Abstract

Objective: To develop and systematize a methodology for constructing datasets for computer vision programs (CVPs) in clinical medicine; to propose and substantiate a multicriteria classification of CVPs and to characterize their clinical use at three organizational levels: the patient, the clinician and the medical organization.

Material and methods. The study systematizes the concepts of "dataset" and "database" in medical artificial intelligence, develops a multicriteria classification of CVPs, and , and characterizes their clinical use. The study employed terminological and comparative analyses, as well as a and classification approach.

Results. The concepts of "dataset" and "database" were clarified, and their key characteristics were formalized. A six-stage methodology for constructing a dataset from a clinical database was described, comprising extraction, de-identification, verification, structuring, balancing, and documentation. A four-criteria classification of CVPs was proposed and substantiated, based on input-data modality, number of models used, deployment setting, and integration with clinical equipment. The clinical application of CVPs was characterized at three organizational levels: the patient, the clinician, and the medical organization.

Conclusion. Proper dataset construction is a key determinant of the clinical validity of CVPs. The proposed classification provides a standardized description of these systems, enabling their valid comparison and regulatory evaluation. The identification of the levels at which CVP is used in clinical practice helps optimize its integration into real-world healthcare settings.

About the Authors

D. I. Korabelnikov
Moscow Haass Medical and Social Institute
Russian Federation

Daniil I. Korabelnikov, PhD, Assoc. Prof. 

5 2nd Brestskaya Str., Moscow 123056



A. I. Lamotkin
Moscow Haass Medical and Social Institute
Russian Federation

Andrey I. Lamotkin 

5 2nd Brestskaya Str., Moscow 123056



References

1. Mennella C., Maniscalco U., De Pietro G., Esposito M. Ethical and regulatory challenges of AI technologies in healthcare: a narrative review. Heliyon. 2024; 10 (4): e26297. https://doi.org/10.1016/j.heliyon.2024.e26297.

2. Lamotkin A.I., Korabelnikov D.I., Lamotkin I.A., et al. Artificial intelligence in healthcare and medicine: the history of key events, its significance for doctors, the level of development in different countries. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2024; 17 (2): 243–50 (in Russ.). https://doi.org/10.17749/2070-4909/farmakoekonomika.2024.254.

3. Hirani R., Noruzi K., Khuram H., et al. Artificial intelligence and healthcare: a journey through history, present innovations, and future possibilities. Life. 2024; 14 (5): 557. https://doi.org/10.3390/life14050557.

4. Matsuzaka Y., Iyoda M. Applications, image analysis, and interpretation of computer vision in medical imaging. Front Radiol. 2026; 5: 1733003. https://doi.org/10.3389/fradi.2025.1733003.

5. Lamotkin A.I., Korabelnikov D.I., Lamotkin I.A., et al. Melanoma check the accuracy of the preliminary diagnosis of malignant melanocytic skin tumors using the artificial intelligence program “Melanoma Check”. Medical Bulletin of the Main Military Cinical Hospital named after N.N. Burdenko. 2025; 1: 42–51 (in Russ.). https://doi.org/10.53652/2782-1730-2025-6-1-42-51.

6. Lamotkin A.I., Korabelnikov D.I., Lamotkin I.A., Glad’ko V.V. Efficacy of preliminary diagnostics of benign tumors of vascular and fibrous skin tissues with the use of artificial intelligence program “Derma Onko Check”. Medical Bulletin of the Ministry of Internal Affairs. 2025; 137 (4): 45–52 (in Russ.). https://doi.org/10.52341/20738080_2025_137_4_45.

7. Almarie B., Gonzalez-Gonzalez L.F., Dos Santos Barbosa L.A., et al. Machine learning-enabled medical devices authorized by the US Food and Drug Administration in 2024: regulatory characteristics, predicate lineage, and transparency reporting. Biomedicines. 2025; 13 (12): 3005. https://doi.org/10.3390/biomedicines13123005.

8. Korabelnikov D.I., Lamotkin A.I. The effectiveness of using artificial intelligence in clinical medicine. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2025; 18 (1): 114–24 (in Russ.). https://doi.org/10.17749/2070-4909/farmakoekonomika.2025.287.

9. Korabelnikov D.I., Lamotkin A.I. Artificial intelligence in oncology: global experience and future prospects. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2025; 18 (3): 437–47 (in Russ.). https://doi.org/10.17749/2070-4909/farmakoekonomika.2025.302.

10. Korabelnikov D.I., Lamotkin A.I. Artificial intelligence in dermatology: a comparative analysis of computer vision programs based on machine learning models. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2025; 18 (4): 571–81 (in Russ.). https://doi.org/10.17749/2070-4909/farmakoekonomika.2025.340.

11. Bergman A., Patel T. A., Shah K.P. Characterizing industry payments for FDA-approved AI medical devices. Health Aff Sch. 2025; 3 (12): qxaf211. https://doi.org/10.1093/haschl/qxaf211.

12. Ламоткин, А. И. Искусственный интеллект в дерматовенерологии: обзор применяемых мобильных приложений на основе моделей искусственного интеллекта / А. И. Ламоткин, Д. И. Корабельников // Клинический разбор в общей медицине. – 2026. – Т. 7, № 1. – С. 95-104. – DOI 10.47407/kr2026.7.1.00761.

13. Ktena, I., Wiles, O., Albuquerque, I., Rebuffi, S. A., Tanno, R., Roy, A. G., Azizi, S., Belgrave, D., Kohli, P., Cemgil, T., Karthikesalingam, A., & Gowal, S. (2024). Generative models improve fairness of medical classifiers under distribution shifts. Nature medicine, 30(4), 1166–1173. https://doi.org/10.1038/s41591-024-02838-6

14. Kim, A., & Jung, I. (2023). Optimal selection of resampling methods for imbalanced data with high complexity. PloS one, 18(7), e0288540. https://doi.org/10.1371/journal.pone.0288540

15. Sivakumar R., Lue B., Kundu S. FDA approval of artificial intelligence and machine learning devices in radiology: a systematic review. JAMA Netw Open. 2025; 8 (11): e2542338. https://doi.org/10.1001/jamanetworkopen.2025.42338.

16. Khalid S.A., Khaliq T., Rehman Y.N., et al. Comparative performance of artificial intelligence and radiologists in detecting lung nodules and breast lesions on CT and MRI: a systematic review. Cureus. 2025; 17 (11): e95943. https://doi.org/10.7759/cureus.95943.

17. Olveres J., González G., Torres F., et al. What is new in computer vision and artificial intelligence in medical image analysis applications. Quant Imaging Med Surg. 2021; 11 (8): 3830–53. https://doi.org/10.21037/qims-20-1151.


Review

For citations:


Korabelnikov D.I., Lamotkin A.I. Computer vision programs in medicine: dataset development, classification, and clinical use. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2026.374

Views: 26

JATS XML

ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)